Oramed Pharmaceuticals (ORMP) Other Working Capital Changes (2022 - 2026)

Oramed Pharmaceuticals (ORMP) has 5 years of Other Working Capital Changes data on file, last reported at -$2.0 million in Q1 2026.

• Quarterly Other Working Capital Changes fell 200100.0% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 4695.12% YoY) and the FY2025 annual result came in at $117000.0, up 172.09% from the prior year.
• Other Working Capital Changes slipped to -$2.0 million in Q1 2026, from $2.1 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.3 million in Q4 2025 to a low of -$674000.0 in Q2 2022.
• A 5-year average of -$11588.2 and a median of -$59000.0 in 2024 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2025 — Other Working Capital Changes soared 14013.33% — and 2026, when it slumped 200100.0%.
• Tracing ORMP's Other Working Capital Changes over 5 years: stood at -$70000.0 in 2022, then tumbled by 1778.57% to -$1.3 million in 2023, then jumped by 101.14% to $15000.0 in 2024, then soared by 14013.33% to $2.1 million in 2025, then plunged by 194.47% to -$2.0 million in 2026.
• The last three Other Working Capital Changes figures came in at -$2.0 million (Q1 2026), $2.1 million (Q4 2025), and -$2.0 million (Q2 2025), per Business Quant data.